Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD) Bilan Comptable

PRLD Prelude Therapeutics Inc

4,09

0,05 (1,24%)

25 Mai 2024 - Fermé

Retardé de 15 minutes

Statistiques

Annuel Trimestriel

Fin d'année 31 Décembre 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-178.959	-144.055	-46.385	-42.253	-43.926	-48.912
Return on Equity (%)	129.379	76.472	-69.95	-44.85	-47.966	-56.335
Return on Invested Capital (%)	-215.437	-181.741	-51.341	-46.1	-52.844	-63.174
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	5.05	4.657	2.427	3.003	2.04	2.16
Earnings Per Share	-5.332	-7.539	-0.651	-1.173	-1.205	-1.11
Cash Per Share	5.665	5.162	2.498	0.334	0.319	0.23
Working Capital Per Share	4.776	4.208	2.396	2.898	1.907	1.948
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-5.332	-7.539	-0.651	-1.173	-1.205	-1.11
EBITDA Per Share	-5.332	-7.539	-0.651	-1.173	-1.205	-1.11
Free Cash Flow Per Share	-5.177	-7.43	-0.65	-1.158	-1.187	-1.089

Liquidity Ratios

Fin d'année 31 Décembre 2023	2018	2019	2020	2021	2022	2023
Current Ratio	6.373	4.183	19.412	15.37	9.418	10.792
Quick Ratio	6.373	3.905	19.192	15.168	9.295	10.671
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Actions en circulation	2,75M	3,66M	32,6M	36,2M	36,5M	42,06M

Statistiques et ratios clés

Fin d'année 31 Décembre 2023	Juin 2022	Sept 2022	Déc 2022	Mar 2023	Juin 2023	Sept 2023	Déc 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Actions en circulation	36,37M	36,45M	36,5M	36,51M	41,96M	41,97M	42,06M	42,07M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	8.914	N/A	N/A	N/A	11.64
Quick Ratio	N/A	N/A	N/A	8.761	N/A	N/A	N/A	11.445
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Statistiques et ratios clés

Capitalisation boursière	224,08M
Ratio cours/bénéfice	-1,84
Ratio prix/ventes	0
Ratio prix/liquidités	8,86
Ratio prix/valeur comptable	0,95
Rendement de dividende	-

Statistiques sur les actions

Actions en circulation	54,92M
Volume moyen (1 semaine)	30,39k
Volume moyen (1 mois)	33,09k
Variation sur 52 semaines	-24,12%
Plus haut sur 52 semaines	6,09
Plus bas sur 52 semaines	1,66

Plus de ratios bientôt disponibles !

Prelude Therapeutics

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales